TC-6987 for the Treatment of Mild to Moderate Asthma
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine whether TC-6987 improves respiratory function in subjects
with asthma by reducing airway hyper-responsiveness and inflammation.